diltiazem has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bailly, JD; Bordier, C; Goubin, F; Jaffrézou, JP; Laredo, J; Laurent, G; Muller, C | 1 |
| Sampi, K | 1 |
2 other study(ies) available for diltiazem and Leukemia
| Article | Year |
|---|---|
Verapamil decreases P-glycoprotein expression in multidrug-resistant human leukemic cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Carrier Proteins; Diltiazem; Drug Resistance; Humans; Leukemia; Membrane Glycoproteins; Neoplasm Proteins; Nifedipine; RNA, Messenger; Tumor Cells, Cultured; Verapamil; Vinblastine | 1994 |
[Cancer chemotherapy combined with a calcium antagonist in patients with hematologic malignancies and solid tumors resistant to standard chemotherapy].
Topics: Acute Disease; Administration, Oral; Antibiotics, Antineoplastic; Diltiazem; Drug Therapy, Combination; Esophageal Neoplasms; Humans; Leukemia; Lymphoma; Naphthacenes; Nicardipine; Remission Induction; Vinca Alkaloids | 1987 |